• Healthcare Marketers Are Suffering from an Identity Crisis—Vince Parry Aims to Solve It

    Panorama by on April 26th, 2017

    Vince Parry, a 30-year veteran of the health and wellness communications industry and the President of the Parry Branding Group, doesn’t think all healthcare marketers know what branding actually means. In his new book, Identity Crisis: Healthcare Branding’s Hidden Problems and Proven Strategies to Solve Them, he explains that too many healthcare marketers incorporate consumer […]

  • How Can You Make Big Data More Manageable and Valuable?

    Panorama by on April 26th, 2017

    “Big data” is the latest buzzword in the consumer and life sciences industries. In today’s complex communications environment, we are awash in incoming data from a variety of sources. The quickly expanding and evolving omni-channel global engagement environment lends itself to gathering data from every corner, and developing a way to use this data for […]

  • Key Principles for Sales and Marketing Messages in the Face of Reduced Access to Oncologists

    Panorama by and on April 26th, 2017

    Oncology treatment breakthroughs provide patients and oncologists with an increased array of innovative treatment options and are fueling growth in today’s pharmaceutical market. However, as personalized cancer treatments become available, access to individual physicians to educate and convey required messaging related to this personalization is becoming more difficult. Relying on traditional broad treatment-centric marketing messages […]

  • Field Medical Function’s Pivotal Role in an Evolving Healthcare Landscape

    Panorama by on April 26th, 2017

    The medical affairs function undoubtedly plays a pivotal role in the success of a brand, not just during the pre-launch phase, but also throughout the product lifecycle. Medical affairs acts as a conduit between Research & Development (R&D) and commercial, working extremely closely with both internal and external stakeholders to ensure appropriate use of interventions […]

  • Ensure Your New Analytics Solutions Doesn’t Become Useless—Achieving Proper Company Adoption

    Panorama by on April 26th, 2017

    The past few years have seen rapid improvements to the most common analytics solutions used in the pharmaceutical industry. We can now deliver more compelling experiences to our business users than ever before—satisfying their voracious appetite for data—big and small. And yet, in spite of the urgency and excitement, companies are not realizing the full […]

  • Patient Advocates Assume a Large Role as Orphan Drug Development Expands

    Panorama by on April 26th, 2017

    “Rare disease” may be the biggest misnomer in the pharmaceutical industry. Around the world, 350 million people live with conditions classified as rare because each afflicts a relatively small segment of the population. In the U.S., 30 million—nearly one in 10 Americans—suffer from one of about 7,000 known rare diseases. As it applies to this […]

  • Expanded Access Programs Require Compassionate Communications to Keep Your Reputation Intact

    Panorama by on March 28th, 2017

    No company wants to be seen as uncaring, least of all in the healthcare space. Clients I’ve supported in this sector are often passionate about their mission to bring new and better treatment options to patients. But companies’ intentions may be undermined or misconstrued if they fail to develop a communications plan for an expanded […]

  • Imagining Tomorrows at SXSW 2017

    Panorama by on March 28th, 2017

    When asked for our impression of SXSW, those of us who have attended the annual gathering will always sound like the three blind men returning with vastly varied stories of the elephant, each altogether incomplete. There’s so much, and ever more, to hear, to learn, to experience, and always too much to fully encapsulate in […]

  • Beyond the Banner: What Happens When Online Ads Stop Working

    Panorama by on March 28th, 2017

    Last month, I was on the phone with a brand manager (let’s call her Suzie) when we both read the news that WebMD may be for sale. The pioneering medical content company lowered financial guidance in 2017, reflecting “a decrease in our biopharma advertising growth rate.” In lay terms, this means, “People aren’t clicking on […]

  • 5 Smart Ways to Increase Medical Affairs Tenure Without Investing Much

    Panorama by on March 28th, 2017

    As a Medical Advisor for almost seven years in Big Pharma, I know what it feels like when you reach a certain level and nobody can clearly explain to you what is next in your Medical Affairs career. Interestingly, the more I tried to take on new tasks or expand my responsibilities to bring more […]

  • How Could the FDA Change Under Scott Gottlieb?

    Panorama by on March 28th, 2017

    Earlier this month, President Trump nominated Dr. Scott Gottlieb to serve as the new FDA Commissioner, pending confirmation by the Senate. Dr. Gottlieb served in several senior leadership roles in the FDA and the CMS, including Deputy Commissioner for Medical and Scientific Affairs at the FDA, during the George W. Bush administration. More recently he […]

  • Five Data Essentials to Remove Commercial Roadblocks

    Panorama by on February 27th, 2017

    Data is foundational to smarter, better decision making and more productive relationships with customers. That is why 78% of commercial operations teams in the life sciences industry have embarked on a data quality initiative, or will do so in the next two years, according to a new survey. In this complex era of personalized medicine […]

  • Vast Majority of Lung Cancer Patients Unaware About Targeted Therapies

    Panorama by on February 27th, 2017

    Only 17% of lung cancer patients were aware whether they had tested positive for a genetic mutation, according to a recent survey conducted by Health Union. The results help to illustrate that the general patient population is still largely unaware of the fact that therapies currently exist that can attack certain mutations such as EGFR, […]

Back to top